Physician profile
Bashar Obeidou
NPI 1033297031
$10,129.06
in general payments reported to CMS, 2019-2025
43 companies · $2,114 in 2025
The $2,114 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $881 · 2020: $1,552 · 2021: $595 · 2022: $1,190 · 2023: $1,333 · 2024: $2,463 · 2025: $2,114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,910.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,618.04 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Edwards Lifesciences Corporation | $1,054.98 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $769.12 | 2019-2025 | Lifevest |
| Novo Nordisk INC | $722.42 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Abbott Laboratories | $563.14 | 2020-2025 | Aveir, Merlin@Home, Jot Dx |
| Boston Scientific Corporation | $514.85 | 2022-2025 | Rotapro, Crossboss, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $410.99 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $390.53 | 2019-2025 | Opsumit, Uptravi |
| Abiomed | $347.40 | 2019-2023 | Impella |
| Pfizer INC. | $297.12 | 2019-2025 | |
| Penumbra, INC. | $255.56 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $217.27 | 2021-2025 | |
| Shockwave Medical, INC | $214.84 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $201.82 | 2022-2025 | Verquvo |
| Medtronic, INC. | $184.71 | 2021-2025 | Micra |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $184.42 | 2023 | |
| Amgen INC. | $183.93 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $183.48 | 2025 | |
| Alnylam Pharmaceuticals INC. | $180.92 | 2023-2025 | Onpattro, Amvuttra |
| Impulse Dynamics (USA) INC. | $180.47 | 2024-2025 | Optimizer |
| Scpharmaceuticals INC. | $161.26 | 2025 | |
| Cardiovascular Systems INC. | $142.46 | 2022-2023 | Diamondback Coronary |
| Philips North America LLC | $125.20 | 2022-2025 | Diagnostic Ecg Service, Visions 035 |
| Lexicon Pharmaceuticals, INC. | $122.10 | 2023 | Inpefa |
| Asahi Intecc USA, INC. | $111.34 | 2019-2023 | Asahi Ptca Guide Wire |
| Janssen Pharmaceuticals, INC | $89.85 | 2019-2022 | |
| Baxter Healthcare | $84.94 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Bridgebio Pharma, INC. | $63.75 | 2025 | Attruby |
| Kestra Medical Technology Services, INC. | $63.12 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.09 | 2024-2025 | Jardiance |
| Amarin Pharma, INC. | $48.61 | 2019-2021 | |
| Irhythm Technologies, INC. | $44.98 | 2024 | Zio Xt Patch, Zio Monitor |
| Terumo Medical Corporation | $44.26 | 2019-2022 | |
| Ge Healthcare | $43.57 | 2019 | |
| Medtronic Vascular, INC. | $40.88 | 2020 | |
| Biotronik INC. | $39.92 | 2022-2024 | Biomonitor |
| Argon Medical Devices, INC. | $39.79 | 2024 | Clot Management |
| Angiodynamics, INC. | $33.33 | 2023 | Auryon Laser System 100-120 Vac |
| Endotronix, INC. | $23.34 | 2025 | Cordella Pulomonary Artery Pressure Sensor |
| Kerecis Limited | $21.00 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tactile Systems Technology INC | $20.54 | 2025 | Flexitouch Plus, Nimbl |
| Sanofi-Aventis U.S. LLC | $18.42 | 2023 | |
| Lilly USA, LLC | $14.30 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Obeidou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.